Check the Coverage Status for ARCALYST® (rilonacept) in Your State
Coverage status results for the top health plans in
based on the lives covered.
This tool is intended to provide a summary of available coverage information for certain prescription drug plans and is not a guarantee of payment, coverage, or reimbursement for ARCALYST for any specific patient. Healthcare providers are responsible for determining coverage and reimbursement information and ensuring the accuracy and completeness of claim submissions for their patients. Coding, coverage, and reimbursement vary significantly by payer, patient, and setting of care and are subject to change. Contact insurer to confirm coverage of ARCALYST. Contact the Kiniksa OneConnect™ patient support program to learn about coverage support.
Source: Managed Markets Insight & Technology, LLC. Database as of December 2025.
ARCALYST HAS BROAD PAYER COVERAGE ACROSS ALL MAJOR PAYER TYPES AND LOW OUT-OF-POCKET COST1
>98% of PA requests have been approved.*
1Eligible commercially insured patients pay as little as $0 per month for ARCALYST treatment with the copay assistance program.†
*Commercial, Medicare, Medicaid, Tricare, and Department of Defense. Based on completed cases in 2025.
†To be eligible for the Kiniksa Copay Assistance Program, your patient must have commercial insurance, must not have Medicare, Medicaid, or other government insurance, and must meet other eligibility criteria. Your patient also must agree to the rules set forth in the terms and conditions for the program.
Helping make treatment support simple for healthcare providers and patients
- Dedicated point of contact for you and your patients
- Benefits verification
- Prior authorization support
- Financial assistance programs, if qualified
- Options for injection training
The Kiniksa OneConnectTM patient support program is made up of a team of experienced individuals, known as Patient Access Leads, with knowledge of insurance plans and healthcare networks.